WO2000038760A3 - Rheological treatment methods and related apheresis systems - Google Patents

Rheological treatment methods and related apheresis systems Download PDF

Info

Publication number
WO2000038760A3
WO2000038760A3 PCT/US1999/030983 US9930983W WO0038760A3 WO 2000038760 A3 WO2000038760 A3 WO 2000038760A3 US 9930983 W US9930983 W US 9930983W WO 0038760 A3 WO0038760 A3 WO 0038760A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood
apheresis
treatments
methods
treatment methods
Prior art date
Application number
PCT/US1999/030983
Other languages
French (fr)
Other versions
WO2000038760A2 (en
Inventor
Richard C Davis
Original Assignee
Occulogix Corp
Richard C Davis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Occulogix Corp, Richard C Davis filed Critical Occulogix Corp
Priority to EP99967651A priority Critical patent/EP1140252A2/en
Priority to AU23900/00A priority patent/AU2390000A/en
Priority to JP2000590710A priority patent/JP2002533169A/en
Publication of WO2000038760A2 publication Critical patent/WO2000038760A2/en
Publication of WO2000038760A3 publication Critical patent/WO2000038760A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3413—Diafiltration
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/84—General characteristics of the apparatus for treating several patients simultaneously
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires

Abstract

Therapeutic apheresis treatments and diagnostic monitoring methods are described, specifically relating to the depletion and/or removal of a broad bandwidth of certain rheologically active elements from the blood of a patient followed by return of the blood so treated to the patient, and to methods or procedures of apheresis treatment, especially biophysiologic blood filtering treatments and computer medicated delivery methods configured to provide such apheresis treatments to patients with certain chronic, age-related, degenerative, atherogenic, thrombotic or inflammatory diseases; especially those associated with RAM accumulation-deposition causing disturbances of blood rheology or microcirculatory impairment.
PCT/US1999/030983 1998-12-29 1999-12-28 Rheological treatment methods and related apheresis systems WO2000038760A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP99967651A EP1140252A2 (en) 1998-12-29 1999-12-28 Rheological treatment methods and related apheresis systems
AU23900/00A AU2390000A (en) 1998-12-29 1999-12-28 Rheological treatment methods and related apheresis systems
JP2000590710A JP2002533169A (en) 1998-12-29 1999-12-28 Rheological treatment method and associated apheresis system

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11414498P 1998-12-29 1998-12-29
US15804999P 1999-10-07 1999-10-07
US60/114,144 1999-10-07
US60/158,049 1999-10-07

Publications (2)

Publication Number Publication Date
WO2000038760A2 WO2000038760A2 (en) 2000-07-06
WO2000038760A3 true WO2000038760A3 (en) 2000-10-19

Family

ID=26811862

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/030983 WO2000038760A2 (en) 1998-12-29 1999-12-28 Rheological treatment methods and related apheresis systems

Country Status (5)

Country Link
US (3) US6551266B1 (en)
EP (1) EP1140252A2 (en)
JP (1) JP2002533169A (en)
AU (1) AU2390000A (en)
WO (1) WO2000038760A2 (en)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627151B1 (en) * 1997-06-13 2003-09-30 Helmut Borberg Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion
US6620382B1 (en) 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US8197430B1 (en) 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6872187B1 (en) * 1998-09-01 2005-03-29 Izex Technologies, Inc. Orthoses for joint rehabilitation
US6371123B1 (en) * 1999-06-11 2002-04-16 Izex Technology, Inc. System for orthopedic treatment protocol and method of use thereof
US7416537B1 (en) * 1999-06-23 2008-08-26 Izex Technologies, Inc. Rehabilitative orthoses
US6827670B1 (en) * 1999-10-11 2004-12-07 Izex Technologies, Inc. System for medical protocol management
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
US7186515B1 (en) 2000-06-02 2007-03-06 University Of Connecticut Health Center Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof
US7179462B2 (en) 2000-06-02 2007-02-20 University Of Connecticut Health Center α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
DE10049393A1 (en) * 2000-10-05 2002-04-25 Braun Melsungen Ag Extracorporeal blood treatment system
US20030040835A1 (en) * 2001-04-28 2003-02-27 Baxter International Inc. A system and method for managing inventory of blood component collection soft goods in a blood component collection facility
US7822621B1 (en) 2001-05-16 2010-10-26 Perot Systems Corporation Method of and system for populating knowledge bases using rule based systems and object-oriented software
US7236940B2 (en) 2001-05-16 2007-06-26 Perot Systems Corporation Method and system for assessing and planning business operations utilizing rule-based statistical modeling
US7831442B1 (en) 2001-05-16 2010-11-09 Perot Systems Corporation System and method for minimizing edits for medical insurance claims processing
US7216088B1 (en) 2001-07-26 2007-05-08 Perot Systems Corporation System and method for managing a project based on team member interdependency and impact relationships
US8949082B2 (en) 2001-11-02 2015-02-03 Siemens Medical Solutions Usa, Inc. Healthcare information technology system for predicting or preventing readmissions
CN1613068A (en) 2001-11-02 2005-05-04 美国西门子医疗解决公司 Patient data mining for diagnosis and projections of patient states
US7313531B2 (en) * 2001-11-29 2007-12-25 Perot Systems Corporation Method and system for quantitatively assessing project risk and effectiveness
US7457731B2 (en) * 2001-12-14 2008-11-25 Siemens Medical Solutions Usa, Inc. Early detection of disease outbreak using electronic patient data to reduce public health threat from bio-terrorism
JP2005538148A (en) * 2002-08-26 2005-12-15 リピド サイエンスィズ インコーポレイテッド Treatment of Alzheimer's disease using defatted protein particles
US7680086B2 (en) 2002-09-09 2010-03-16 Siemens Canada Limited Wireless local area network with clients having extended freedom of movement
JP2007527387A (en) * 2003-07-03 2007-09-27 リピッド サイエンシーズ，インコーポレイテッド Method and apparatus for producing particle derivatives of HDL with reduced lipid content
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
DK1949915T3 (en) * 2004-04-30 2012-11-26 Biopheresis Technologies Inc Method and system for removing soluble TNFR1, TNRF2 and IL2R in patients
AT500483B1 (en) * 2004-07-13 2006-01-15 Mattner Frank Dr Kit for prevention or treatment of Alzheimer's disease comprises means for inducing sequestration of amyloid beta in plasma and apheresis apparatus which exhibits an amyloid beta precursor protein receptor
WO2006017763A2 (en) * 2004-08-04 2006-02-16 Aspira Biosystems, Inc. Capture and removal of biomolecules from body fluids using partial molecular imprints
EP1778207A2 (en) * 2004-08-18 2007-05-02 Sytera Inc. Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
EP1819278A4 (en) * 2004-11-15 2009-04-08 Izex Technologies Inc Instrumented orthopedic and other medical implants
US8308794B2 (en) 2004-11-15 2012-11-13 IZEK Technologies, Inc. Instrumented implantable stents, vascular grafts and other medical devices
JP4992104B2 (en) * 2005-03-29 2012-08-08 旭化成メディカル株式会社 Module for hemofiltration or hemodiafiltration
US20060265253A1 (en) * 2005-05-18 2006-11-23 Rao R B Patient data mining improvements
US8527292B1 (en) * 2005-07-01 2013-09-03 Smartmc, LLC Medical data analysis service
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
US20070219824A1 (en) * 2006-03-17 2007-09-20 Jean Rawlings System and method for identifying and analyzing patterns or aberrations in healthcare claims
US7758505B2 (en) * 2006-04-03 2010-07-20 Elfi-Tech Ltd. Methods and apparatus for non-invasive determination of patient's blood conditions
US20080097935A1 (en) * 2006-10-11 2008-04-24 Boyer Midred E Access housing
US8540517B2 (en) * 2006-11-27 2013-09-24 Pharos Innovations, Llc Calculating a behavioral path based on a statistical profile
US8540516B2 (en) * 2006-11-27 2013-09-24 Pharos Innovations, Llc Optimizing behavioral change based on a patient statistical profile
US8540515B2 (en) * 2006-11-27 2013-09-24 Pharos Innovations, Llc Optimizing behavioral change based on a population statistical profile
US20090164245A1 (en) * 2007-12-19 2009-06-25 Chakravarthy Srinivasa Kalyan Toleti System and method of obtaining informed consent
EP2110140A1 (en) 2008-04-18 2009-10-21 Gert Baumann Treatment of thromboangiitis obliterans by removal of autoantibodies
WO2010033816A1 (en) * 2008-09-18 2010-03-25 Ingenix, Inc. Apparatus, system and method for graphically displaying natural history of disease progression
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
EP2361645B1 (en) * 2008-12-22 2014-10-29 Fujita Health University Use of a carrier for removal amyloid beta protein from extracorporeal fluids
US20110046974A1 (en) * 2009-08-21 2011-02-24 Greg Burks Systems and methods for monitoring and reporting lab results
US8751495B2 (en) * 2009-09-29 2014-06-10 Siemens Medical Solutions Usa, Inc. Automated patient/document identification and categorization for medical data
US20110184761A1 (en) * 2010-01-25 2011-07-28 Siemens Medical Solutions Usa, Inc. Method and Apparatus for Estimating Patient Populations
US20120323158A1 (en) * 2010-03-10 2012-12-20 Paul Tebbey Extracorporeal immunoadsorption treatment
US10943676B2 (en) 2010-06-08 2021-03-09 Cerner Innovation, Inc. Healthcare information technology system for predicting or preventing readmissions
US20130068691A1 (en) * 2011-08-05 2013-03-21 Henry John Smith Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders
EP2753644A1 (en) 2011-09-09 2014-07-16 Universiteit Utrecht Holding B.V. Broadly neutralizing vhh against hiv-1
US10286148B2 (en) * 2012-01-23 2019-05-14 Fenwal, Inc. Using physiological data in a medical device
EP2827882B1 (en) * 2012-02-21 2020-04-08 Cytonics Corporation Systems, compositions, and methods for transplantation
US10624924B2 (en) * 2012-03-12 2020-04-21 Grifols, S.A. Method and device for treating blood cholesterol disorders
US10565315B2 (en) 2012-09-28 2020-02-18 Cerner Innovation, Inc. Automated mapping of service codes in healthcare systems
US10403391B2 (en) 2012-09-28 2019-09-03 Cerner Health Services, Inc. Automated mapping of service codes in healthcare systems
US10318635B2 (en) 2012-09-28 2019-06-11 Cerner Innovation, Inc. Automated mapping of service codes in healthcare systems
US10540448B2 (en) 2013-07-15 2020-01-21 Cerner Innovation, Inc. Gap in care determination using a generic repository for healthcare
CA2922806A1 (en) 2013-08-28 2015-03-05 Cytonics Corporation Systems, compositions, and methods for transplantation and treating conditions utilizing a composition comprising a wild-type or a variant a2m polypeptide or portion thereof
AU2015201496B2 (en) 2014-06-03 2019-10-31 Grifols Worldwide Operations Limited Use of plasmapheresis to treat blood pressure disorders
CA3029970A1 (en) * 2015-07-07 2017-01-12 Nashwa KHALIL Autoimmune mechanical immunomodulation
EP3220298A1 (en) 2016-03-14 2017-09-20 Fenwal, Inc. Cell processing system and method with process parameter control
EP3940706A1 (en) 2016-05-27 2022-01-19 Fenwal, Inc. Cell processing system and method with preliminary process evaluation
US10654000B2 (en) 2016-07-13 2020-05-19 Fenwal, Inc. Cell processing system and method with centralized data management, monitoring and/or control
WO2019104237A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
US20190160333A1 (en) * 2017-11-28 2019-05-30 International Business Machines Corporation Adaptive fitness training
AU2018396009A1 (en) 2017-12-28 2020-07-16 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
WO2023129766A1 (en) * 2021-12-27 2023-07-06 Onl Therapeutics, Inc. Sfasl for inhibiting rpe cell death and associated disorders

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041350A2 (en) * 1980-05-29 1981-12-09 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
US4402940A (en) * 1982-03-12 1983-09-06 Kuraray Co., Ltd. Method for treating blood plasma employing a hollow fiber membrane
EP0120445A2 (en) * 1983-03-24 1984-10-03 B. Braun-SSC AG Method and device for the selective extracorporeal separation of pathological and/or toxic blood components
WO1990014850A1 (en) * 1989-05-31 1990-12-13 Hospal A.G. Management of parameters relating to a dialysis treatment
US5606976A (en) * 1994-07-26 1997-03-04 Trustees Of The University Of Pennsylvania Method and apparatus for unifying the ventilation/perfusion and pressure/flow models
WO1998002836A2 (en) * 1996-07-12 1998-01-22 Iliff Edwin C Computerized medical diagnostic system utilizing list-based processing
US5781442A (en) * 1995-05-15 1998-07-14 Alaris Medical Systems, Inc. System and method for collecting data and managing patient care

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619639A (en) 1980-02-05 1986-10-28 Asahi Medical Co., Ltd. Method and apparatus for low pressure filtration of plasma from blood
JPS583705B2 (en) * 1980-07-18 1983-01-22 川澄化学工業株式会社 Double filtration plasma exchange device
US4708713A (en) 1984-11-16 1987-11-24 Anisa Medical, Inc. Method and system for removing immunosuppressive components from the blood of mammals
US5782792A (en) 1986-11-21 1998-07-21 Cypress Bioscience, Inc. Method for treatment of rheumatoid arthritis
US5733254A (en) 1987-10-15 1998-03-31 Cypress Bioscience, Inc. Method for treating patients suffering from immune thrombocytopenic purpura
US5286449A (en) 1988-04-04 1994-02-15 Asahi Medical Co., Ltd. Adsorber module for whole blood treatment and an adsorber apparatus containing the adsorber module
US5276611A (en) 1989-05-25 1994-01-04 Andrea Ghiraldi Management of parameters relating to a dialysis treatment
US5536412A (en) 1992-02-06 1996-07-16 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5377258A (en) 1993-08-30 1994-12-27 National Medical Research Council Method and apparatus for an automated and interactive behavioral guidance system
US5734837A (en) 1994-01-14 1998-03-31 Action Technologies, Inc. Method and apparatus for building business process applications in terms of its workflows
US5720921A (en) 1995-03-10 1998-02-24 Entremed, Inc. Flow electroporation chamber and method
US5769811A (en) * 1995-10-31 1998-06-23 Haemonetics Corporation Blood-processing machine system
AU3385797A (en) 1996-06-21 1998-01-07 Appintec Corporation Method and apparatus for improved contact and activity management and planning
US5922278A (en) * 1996-11-19 1999-07-13 Baxter International Inc. Method and apparatus for inactivating contaminants in biological fluid
US6245038B1 (en) 1997-01-07 2001-06-12 Helmut Borberg Method for treatment of ophthalmological diseases
US6230142B1 (en) * 1997-12-24 2001-05-08 Homeopt, Llc Health care data manipulation and analysis system

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041350A2 (en) * 1980-05-29 1981-12-09 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
US4402940A (en) * 1982-03-12 1983-09-06 Kuraray Co., Ltd. Method for treating blood plasma employing a hollow fiber membrane
EP0120445A2 (en) * 1983-03-24 1984-10-03 B. Braun-SSC AG Method and device for the selective extracorporeal separation of pathological and/or toxic blood components
WO1990014850A1 (en) * 1989-05-31 1990-12-13 Hospal A.G. Management of parameters relating to a dialysis treatment
US5606976A (en) * 1994-07-26 1997-03-04 Trustees Of The University Of Pennsylvania Method and apparatus for unifying the ventilation/perfusion and pressure/flow models
US5781442A (en) * 1995-05-15 1998-07-14 Alaris Medical Systems, Inc. System and method for collecting data and managing patient care
WO1998002836A2 (en) * 1996-07-12 1998-01-22 Iliff Edwin C Computerized medical diagnostic system utilizing list-based processing

Also Published As

Publication number Publication date
US20080040153A1 (en) 2008-02-14
US6551266B1 (en) 2003-04-22
WO2000038760A2 (en) 2000-07-06
US20030127390A1 (en) 2003-07-10
JP2002533169A (en) 2002-10-08
AU2390000A (en) 2000-07-31
EP1140252A2 (en) 2001-10-10

Similar Documents

Publication Publication Date Title
WO2000038760A3 (en) Rheological treatment methods and related apheresis systems
WO2002095352A3 (en) Patient compliance and monitoring system
CA2549550A1 (en) Botulinum toxin therapy for skin disorders
IL139230A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds to the upper respiratory tract and/or the ear
HU9301978D0 (en) Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin
HUP9700603A1 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
WO2007047122A3 (en) Electrode assembly and handpiece with adjustable system impedance, and methods of operating an energy-based medical system to treat tissue
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
AU3183297A (en) Lectin compositions and uses thereof
ATE77751T1 (en) MEANS FOR TREATMENT OF BONE DISEASES.
AU2001261987A1 (en) Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
BG101126A (en) The use of muramylpeptide compounds
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
AU3401093A (en) Therapeutic agent for threatened abortion
HK1016508A1 (en) Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment...
AU3338699A (en) Medical devices treated to discourage blood coagulation
MXPA03011186A (en) Use of long pentraxin ptx3 for the treatment of fgf-8 mediated tumour diseases.
CA2267543A1 (en) Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
BR0014374A (en) Combination of loteprednol and beta two adrenoreceptor agonists
AUPP797598A0 (en) Therapeutic agent
WO2002043566A3 (en) Devices and methods for treating low blood sugar levels
NO953003L (en) Use of ifenprodil and its diastereoisomers for the preparation of medical preparations
SU1704782A1 (en) Method for treating the cases of alveolitis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999967651

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 590710

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1999967651

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642